Lumayaga, Carmie V.

HRN: 26-30-21  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/28/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
11/28/2024
11/28/2024
IV
4.5g
LD
Septicemia
Waiting Final Action 
11/28/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/28/2024
12/04/2024
IV
2.25gm
Q6
Septicemia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: